PURPOSE: Plus disease has become the major criterion for laser treatment in infants with retinopathy of prematurity (ROP), but its assessment is subjective. Our purpose was to compare quadrant-level and eye-level assessment of plus disease and pre-plus disease among 3 experienced ROP examiners and to report their rate of agreement. METHODS: One hundred eighty-one high-quality RetCam images from premature infants were graded by 3 of the authors. Dilation and tortuosity were judged separately using a scale of normal or sufficiently abnormal to meet criteria for pre-plus or plus disease. RESULTS: There was disagreement on the presence of plus disease for 18 images (10%), on tortuosity sufficient for plus disease (plus tortuosity) for 26 images (14%), and on dilation sufficient for plus disease (plus dilation) for 26 images (14%). Of 67 images judged to have pre-plus disease or worse, there was disagreement on the presence of plus disease for 18 images (27%), on plus tortuosity for 25 images (37%), and on plus dilation for 21 images (31%). For distinguishing plus or pre-plus disease from normal, there was disagreement on pre-plus tortuosity for 38 of 181 images (21%) and on pre-plus dilation for 58 of 181 images (32%). CONCLUSIONS: Three experienced ROP examiners disagreed frequently on the diagnosis of plus or pre-plus disease when evaluating cropped clinical photographs of infants, many of which had borderline plus disease. Further study is required to determine the implications of these observations on clinical decision making.
PURPOSE: Plus disease has become the major criterion for laser treatment in infants with retinopathy of prematurity (ROP), but its assessment is subjective. Our purpose was to compare quadrant-level and eye-level assessment of plus disease and pre-plus disease among 3 experienced ROP examiners and to report their rate of agreement. METHODS: One hundred eighty-one high-quality RetCam images from premature infants were graded by 3 of the authors. Dilation and tortuosity were judged separately using a scale of normal or sufficiently abnormal to meet criteria for pre-plus or plus disease. RESULTS: There was disagreement on the presence of plus disease for 18 images (10%), on tortuosity sufficient for plus disease (plus tortuosity) for 26 images (14%), and on dilation sufficient for plus disease (plus dilation) for 26 images (14%). Of 67 images judged to have pre-plus disease or worse, there was disagreement on the presence of plus disease for 18 images (27%), on plus tortuosity for 25 images (37%), and on plus dilation for 21 images (31%). For distinguishing plus or pre-plus disease from normal, there was disagreement on pre-plus tortuosity for 38 of 181 images (21%) and on pre-plus dilation for 58 of 181 images (32%). CONCLUSIONS: Three experienced ROP examiners disagreed frequently on the diagnosis of plus or pre-plus disease when evaluating cropped clinical photographs of infants, many of which had borderline plus disease. Further study is required to determine the implications of these observations on clinical decision making.
Authors: Anna L Ells; Jonathan M Holmes; William F Astle; Geoff Williams; David A Leske; Michael Fielden; Brad Uphill; Penny Jennett; Marilynne Hebert Journal: Ophthalmology Date: 2003-11 Impact factor: 12.079
Authors: S F Freedman; J A Kylstra; J J Capowski; T D Realini; C Rich; D Hunt Journal: J Pediatr Ophthalmol Strabismus Date: 1996 Jul-Aug Impact factor: 1.402
Authors: Michael F Chiang; Michele Melia; Angela N Buffenn; Scott R Lambert; Franco M Recchia; Jennifer L Simpson; Michael B Yang Journal: Ophthalmology Date: 2012-04-27 Impact factor: 12.079
Authors: Preeti J Thyparampil; Yangseon Park; M E Martinez-Perez; Thomas C Lee; David J Weissgold; Audina M Berrocal; R V Paul Chan; John T Flynn; Michael F Chiang Journal: Am J Ophthalmol Date: 2010-10 Impact factor: 5.258
Authors: Chace Moleta; J Peter Campbell; Jayashree Kalpathy-Cramer; R V Paul Chan; Susan Ostmo; Karyn Jonas; Michael F Chiang Journal: Am J Ophthalmol Date: 2017-01-11 Impact factor: 5.258
Authors: Esra Ataer-Cansizoglu; Jayashree Kalpathy-Cramer; Susan Ostmo; Karyn Jonas; R V Paul Chan; J Peter Campbell; Michael F Chiang; Deniz Erdogmus Journal: Conf Proc IEEE Eng Med Biol Soc Date: 2016-08
Authors: Rolando Estrada; Carlo Tomasi; Michelle T Cabrera; David K Wallace; Sharon F Freedman; Sina Farsiu Journal: Biomed Opt Express Date: 2012-01-18 Impact factor: 3.732
Authors: Hilal Biten; Travis K Redd; Chace Moleta; J Peter Campbell; Susan Ostmo; Karyn Jonas; R V Paul Chan; Michael F Chiang Journal: JAMA Ophthalmol Date: 2018-05-01 Impact factor: 7.389
Authors: Jane S Myung; Rony Gelman; Grant D Aaker; Nathan M Radcliffe; R V Paul Chan; Michael F Chiang Journal: Am J Ophthalmol Date: 2011-10-22 Impact factor: 5.258